Hints and tips:
...Results: Pharmaceutical companies Eli Lilly, Merck and Bristol Myers Squibb report results today, as do Southwest Airlines, Caterpillar and Honeywell....
...Just last week, Eli Lilly, the producer of popular insulin medications Humalog and Humulin, pledged to reduce its insulin list prices by 70 per cent in an effort to make the medicine more affordable....
...India, which passed 5m cases, will buy 100m doses of Russia’s Sputnik-V vaccine candidate. Eli Lilly’s antibody treatment reduced hospitalisations....
...It has also signed deals with Vir Biotechnology to produce Covid-19 antibody products and with Eli Lilly and AstraZeneca to produce Covid-19 treatments. Song Jung-a 74....
...The popularity of the hypothesis has fallen in recent years after drugs from Merck & Co, Eli Lilly and AstraZeneca, stumbled in final Phase III trials....
...In sifting through the S&P 500, it has chosen to only include companies with 0-45 per cent tax rates, so as to eliminate bizarre outliers such as pharmaceutical company Eli Lilly, who reported a tax rate...
...The amyloid hypothesis has fallen in popularity in recent years after a string of high-profile failures from companies including Merck & Co, Eli Lilly, and AstraZeneca....
...The government has vowed to tackle the price of cancer medicines, threatening revenues for multinationals such as Eli Lilly, Roche and Novartis....
...Lilly, Merck, Roche, Novartis and Takeda Pharmaceuticals....
...Eli Lilly published first quarter earnings that were slightly ahead of expectations as it announced that its experimental breast cancer drug had succeeded in a late-stage clinical trial....
...“Most of the innovative drugs being developed in China are in the me-too category,” says Lin Liang, of Eli Lilly’s Asian venture capital arm, which has poured nearly $500m into mostly Chinese start-ups since...
...Rival Eli Lilly announced job cuts and a focus on new medicines while AstraZeneca was boosted by good news on its cancer pipeline....
...The tenure of David Ricks as Eli Lilly’s chief executive was not supposed to start like this....
...The failure of the Verubecestat trial comes just months after Eli Lilly announced that one of its experimental medicines, Solanezumab, had flunked a late-stage trial of patients with mild Alzheimer’s....
...Were fruquintinib — developed jointly with Eli Lilly — to obtain approval from the US Food and Drug Administration, it would the first modern drug developed in China to be sold on the global market....
...Lilly said Solanezumab had failed its Phase III trial....
...) Eli Lilly mulls spin-off or sale of animal health business (FastFT) Cargill ramps up animal nutrition business with Diamond V deal (FastFT) Asian buyers tap into ‘pampered pooch’ market (FT) ICE to...
...Eli Lilly’s drug, which the company believed could be the first to delay the fatal disease, is called Solanezumab, or Sola....
...Several pharmaceutical chief executives attended the meeting at the White House, including Ken Frazier of Merck & Co, Joe Jimenez of Novartis and David Ricks of Eli Lilly....
...The suspense inside the offices of Eli Lilly this autumn was all but unbearable....
...III,” said analysts at Jefferies. The view was echoed by strategists at Mizuho, who said: “Overall, we believe today’s Eli Lilly results are positive for Biogen.”...
...Biogen has since started enrolling patients in two large “Phase III” studies and Dr Sandrock said that the company was hoping to find a dosage that was both highly effective and safe....
...Eli Lilly has pulled the plug on a potential blockbuster medicine intended to ward off heart attacks and strokes, sending the company’s shares down as much as 10 per cent and dealing a blow to its strategy...
...However, scientists and analysts cautioned that the Eli Lilly data were far from conclusive and that, even if it does eventually prove successful, solanezumab is still years from market....
...Several other companies, including Eli Lilly and Biogen, are also racing to develop treatments for the disease, although the risk of failure is high given the large proportion of Alzheimer’s drugs that do...
International Edition